T. Kondo et al., Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells, TRANSPLANT, 69(5), 2000, pp. 969-977
Background Increased expression of chemokine mRNA is observed in allogeneic
but not syngeneic skin grafts 3-4 days aft:er transplantation. The recipie
nt cells mediating this early inflammatory response in allografts remain un
identified,
Methods. Isogeneic and allogeneic skin grafts were transplanted to euthymic
and athymic nude mice. mRNA expression and protein production of macrophag
e inflammatory protein-1 alpha (MIP-1 alpha), MIP-1 beta, and the murine ho
molog of Gro alpha, i.e. KC, from graft homogenates retrieved 3-4 days post
transplantation was tested by Northern blot hybridization and ELISA. To dep
lete NK cells, recipients were treated with anti-asialo GM1 (ASGM1) antiser
a or with anti-NK1.1 mAb before transplantation.
Results. Express:ion of KC, MIP-1 alpha, and MIP-1 beta mRNA was equivalent
in C57BL/6 allogeneic skin grafts and BALB/c isografts at day 2 posttransp
lant. At day 3 posttransplant, chemokine mRNA levels decreased in isografts
but were maintained at high levels in the allografts. Increased early chem
okine mRNA was also observed in C57BL/6, but not BALB/c(++) grafts on BALB/
c athymic(nu/nu) recipients. Treatment of allograft recipients with ASGM1 o
r with anti-NK1.1 antibody eliminated NM cells from the spleen and allograf
t infiltrating cell populations and decreased early chemokine mRNA levels i
n allografts 60-70%, Analyses of allograft homogenates indicated increased
levels of KC, MIP-l alpha, and MIP-1 beta protein at day 4 posttransplant t
hat were decreased in recipients depleted of NR cells, Early chemokine mRNA
levels were equivalent in isogeneic and semiallogeneic Fl grafts.
Conclusions, Early chemokine mRNA expression and protein production in allo
geneic skin grafts is amplified by recipient natural killer (NM) cells. The
se results indicate a novel. function for infiltrating NK cells in mediatin
g early increased intra-allograft chemokine production and inflammation dur
ing the initiation of acute rejection.